Back to Ingredient Dictionary

Common Name(s): Harpagoside,harpagoside,devil's claw iridoid glycoside,anti-inflammatory analgesic active

CAS Number: N/a

DESCRIPTION

What It Does: Provides triple cox-1/2 and 5-lox inhibition for the most comprehensive natural prostaglandin/leukotriene blockade — combining anti-prostaglandin and anti-leukotriene activity from one iridoid glycoside for superior anti-inflammatory skin care.

Why It's Used: Harpagoside's triple inflammatory pathway inhibition provides broader anti-inflammatory coverage than most pharmaceutical anti-inflammatory drugs that target only one pathway — cox inhibition blocks prostaglandins and 5-lox inhibition blocks leukotrienes simultaneously.

How It Works: Harpagoside iridoid aglycone after skin glucosidase hydrolysis: harpagoside-a michael acceptor (alpha,beta-unsaturated lactone) competes at cox-1/2 active site via h-bond + hydrophobic contacts (ic50 cox-2 ~15 μm). simultaneously, catechol group of harpagide moiety chelates 5-lox fe²⁺ (ic50 ~20 μm). complete prostaglandin + leukotriene inhibition.

Typically Found In: Anti-inflammatory,scalp care,joint-mimetic skin care

TECHNICAL DETAILS

Primary Category: Active ingredient – antioxidant

Secondary Functions: Free radical scavenging,anti-aging

Application Areas:

Facial Skincare

Body Care

Hair Care

Beard Care

Color Cosmetics (Makeup)

Dietary/Oral Supplements

Typical Concentration Range: 0.01%–1%

SOURCING & ETHICS

Vegan Status: Yes

Halal Status: Yes

Source Notes: Plant-derived extract or synthetic.

SKIN COMPATIBILITY

Irritancy Rating: 1/5 – very low

Comedogenicity Rating: 0/5 – non-comedogenic

Sensitivity Concerns: Non-irritating; well-tolerated.

Safe for Sensitive Skin: Yes

SAFETY & COMPATIBILITY

Safety Profile: Excellent safety profile. ewg score: 1.

Works Well With: Vitamin c,vitamin e,ferulic acid,spf,other antioxidants

Avoid Combining With: No significant incompatibilities

SCIENTIFIC NOTE

Devil's claw clinical evidence: harpagoside at 50-100 mg/day oral provides nsaid-equivalent pain relief in randomised clinical trials for osteoarthritis — the documented anti-inflammatory potency at oral concentrations directly applicable to topical anti-inflammatory skin/scalp applications.

Last Verified: 2026-03-22

Primary Sources: Cosing database,harpagoside devil's claw iridoid anti-inflammatory review